Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 29 results.
User Information
Export Records
  1. 1.   Tumor eradication by hetIL-15 locoregional therapy correlates with an induced intratumoral CD103intCD11b+ dendritic cell population
  2. Stellas, Dimitris; Karaliota,Sevasti; Stravokefalou, Vasiliki; Angel, Matthew; Nagy,Bethany; Goldfarbmuren,Kate; Bergamaschi, Cristina; Felber,Barbara; Pavlakis,George
  3. Cell Reports. 2023, May 12; 42(5): 112501.
  1. 2.   Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC
  2. Stravokefalou, Vasiliki; Stellas, Dimitris; Karaliota,Sevasti; Nagy,Bethany; Valentin, Antonio; Bergamaschi, Cristina; Dimas, Konstantinos; Pavlakis,George
  3. Frontiers in Immunology. 2022, Jan 13; 13: 1014802.
  1. 3.   Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies
  2. Bergamaschi, Cristina; Pagoni, Maria; Rosati,Margherita; Angel, Matthew; Tzannou, Ifigeneia; Vlachou, Margarita; Darmani, Ismini; Ullah,Amirah; Bear,Jenifer; Devasundaram,Santhi; Burns,Robert; Baltadakis, Ioannis; Gigantes, Stavros; Dimopoulos, Meletios-Athanasios; Pavlakis,George; Terpos, Evangelos; Felber,Barbara
  3. Frontiers in Immunology. 2022 13: 899972.
  1. 4.   Systemic IL-15, IFN-?, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients
  2. Bergamaschi,Cristina; Terpos, Evangelos; Rosati,Margherita; Angel,Matthew; Bear,Jenifer; Stellas,Dimitris; Karaliota,Sevasti; Apostolakou, Filia; Bagratuni, Tina; Patseas, Dimitris; Gumeni, Sentiljana; Trougakos, Ioannis P; Dimopoulos, Meletios A; Felber,Barbara; Pavlakis,George
  3. Cell reports. 2021, Aug 10; 36(6): 109504.
  1. 5.   The Timing and Abundance of IL-2R beta (CD122) Expression Control Thymic iNKT Cell Generation and NKT1 Subset Differentiation
  2. Won, Hee Yeun; Kim, Hye Kyung; Crossman, Assiatu; Awasthi,Roackie; Gress, Ronald E.; Park, Jung-Hyun
  3. Frontiers in immunology. 2021, May 14; 12
  1. 6.   Heterodimeric IL-15 in Cancer Immunotherapy
  2. Bergamaschi,Cristina; Stravokefalou,Vasiliki; Stellas,Dimitris; Karaliota,Sevasti; Felber,Barbara; Pavlakis,George
  3. Cancers. 2021, Feb 17; 13(4):
  1. 7.   Metabolic but not transcriptional regulation by PKM2 is important for Natural Killer cell responses
  2. Walls,Jessica; Subleski,Jeff; Palmieri,Erika; Gonzalez-Cotto,Marieli; Gardiner, Clair M; McVicar,Daniel; Finlay, David K
  3. eLife. 2020, Aug 19; 9: pii: e59166.
  1. 8.   Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-?, CXCL9 and CXCL10
  2. Bergamaschi,Cristina; Pandit,Hrishikesh; Nagy,Bethany; Stellas,Dimitris; Jensen, Shawn M; Bear,Jenifer; Cam,Maggie; Valentin,Antonio; Fox, Bernard A; Felber,Barbara; Pavlakis,George
  3. Journal for immunotherapy of cancer. 2020, May; 8(1): e000599.
  1. 9.   rhIL-15 and anti-PD-L1 combination therapy expands a CXCR3+PD1-/low CD8 T cell subset in SIV-infected rhesus macaques
  2. Chen, Ping; Chen, Hui; Moussa, Maha; Cheng, Jie; Li, Tong; Qin, Jing; Lifson,Jeffrey; Sneller, Michael C; Krymskaya,Ludmila; Godin, Steven; Lane, H Clifford; Catalfamo, Marta
  3. The Journal of infectious diseases. 2020, Feb 15; 221(4): 523-533.
  1. 10.   IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
  2. Conlon, Kevin C.; Potter, E. Lake; Pittaluga, Stefania; Lee, Chyi-Chia Richard; Miljkovic, Milos D.; Fleisher, Thomas A.; Dubois, Sigrid; Bryant, Bonita R.; Petrus, Michael; Perera, Liyanage P.; Hsu, Jennifer; Figg, William D.; Peer, Cody J.; Shih, Joanna H.; Yovandich,Jason; Creekmore,Stephen; Roederer, Mario; Waldmann, Thomas A.
  3. CLINICAL CANCER RESEARCH. 2019, Aug 15; 25(16): 4945-4954.
  1. 11.   IL-15/IL-15R alpha/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice
  2. Shi, Yimin; Dincheva-Vogel, Lillie; Ayemoba, Charles E.; Fung, Jeffrey P.; Bergamaschi, Cristina; Pavlakis, George; Farzaneh, Farzin; Gaensler, Karin M. L.
  3. BLOOD ADVANCES. 2018, NOV 27; 2(22): 3177-3192.
  1. 12.   Optimized administration of hetIL-15 expands lymphocytes and minimizes toxicity in rhesus macaques
  2. Bergamaschi, Cristina; Watson, Dennis; Valentin, Antonio; Bear, Jenifer; Peer, Cody J; Figg, William D; Felber, Barbara; Pavlakis, George
  3. Cytokine. 2018, Aug; 108: 213-224.
  1. 13.   Configuration-dependent Presentation of Multivalent IL-15:IL-15Ralpha Enhances the Antigen-specific T Cell Response and Anti-tumor Immunity
  2. Hong, E.; Usiskin, I. M.; Bergamaschi, C.; Hanlon, D. J.; Edelson, R. L.; Justesen, S.; Pavlakis, G. N.; Flavell, R. A.; Fahmy, T. M.
  3. The Journal of biological chemistry. 2016, 22-Apr; 291(17): 8931-50.
  1. 14.   Hydrodynamic Delivery of Human IL-15 cDNA Increases Murine Natural Killer Cell Recovery after Syngeneic Bone Marrow Transplantation
  2. Barao, I.; Alvarez, M.; Redelman, D.; Weiss, J. M.; Ortaldo, J. R.; Wiltrout, R. H.; Murphy, W. J.
  3. Biology of Blood and Marrow Transplantation. 2011, Dec; 17(12): 1754-1764.
  1. 15.   IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization
  2. Han, K. P.; Zhu, X. Y.; Liu, B.; Jeng, E.; Kong, L.; Yovandich, J. L.; Vyas, V. V.; Marcus, W. D.; Chavaillaz, P. A.; Romero, C. A.; Rhode, P. R.; Wong, H. C.
  3. Cytokine. 2011, Dec; 56(3): 804-810.
  1. 16.   Simultaneous Blockade of Multiple Immune System Inhibitory Checkpoints Enhances Antitumor Activity Mediated by Interleukin-15 in a Murine Metastatic Colon Carcinoma Model
  2. Yu, P.; Steel, J. C.; Zhang, M. L.; Morris, J. C.; Waldmann, T. A.
  3. Clinical Cancer Research. 2010, Dec; 16(24): 6019-6028.
  1. 17.   Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys
  2. Zielinski, R. J.; Smedley, J. V.; Perera, P. Y.; Silvera, P. M.; Waldmann, T. A.; Capala, J.; Perera, L. P.
  3. Vaccine. 2010, Oct; 28(43): 7081-7091.
  1. 18.   Secretion and Biological Activity of Short Signal Peptide IL-15 Is Chaperoned by IL-15 Receptor Alpha In Vivo
  2. Bergamaschi, C.; Jalah, R.; Kulkarni, V.; Rosati, M.; Zhang, G. M.; Alicea, C.; Zolotukhin, A. S.; Felber, B. K.; Pavlakis, G. N.
  3. Journal of Immunology. 2009 183(5): 3064-3072.
  1. 19.   Expression of Interleukin-15 and Its Receptor on the Surface of Stimulated Human Umbilical Vein Endothelial Cells
  2. Liu, X. P.; Zuo, Y. M.; Zhang, W. N.; Yang, D. G.; Xiong, C. Y.; Zhang, X. Z.
  3. Journal of Huazhong University of Science and Technology-medical Sciences. 2009 29(5): 527-534.
  1. 20.   Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer
  2. Zhang, M. L.; Yao, Z. S.; Dubois, S.; Ju, W.; Muller, J. R.; Waldmann, T. A.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(18): 7513-7518.
  1. 21.   Novel Human Interleukin-15 Agonists
  2. Zhu, X. Y.; Marcus, W. D.; Xu, W. X.; Lee, H. I.; Han, K. P.; Egan, J. O.; Yovandich, J. L.; Rhode, P. R.; Wong, H. C.
  3. Journal of Immunology. 2009 183(6): 3598-3607.
  1. 22.   Intracellular interaction of interleukin-15 with its receptor alpha during production leads to mutual stabilization and increased bioactivity
  2. Bergamaschi, C.; Rosati, M.; Jalah, R.; Valentin, A.; Kulkarni, V.; Alicea, C.; Zhang, G. M.; Patel, V.; Felber, B. K.; Pavlakis, G. N.
  3. Journal of Biological Chemistry. 2008 283(7): 4189-4199.
  1. 23.   The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells
  2. Wuest, T. Y.; Willette-Brown, J.; Durum, S. K.; Hurwitz, A. A.
  3. Journal of Leukocyte Biology. 2008 84(4): 973-980.
  1. 24.   Autoimmunity, spontaneous tumourigenesis, and IL-15 insufficiency in mice with a targeted disruption of the tumour suppressor gene FusI
  2. Ivanova, A. V.; Ivanov, S. V.; Pascal, V.; Lumsden, J. M.; Ward, J. M.; Morris, N.; Tessarolo, L.; Anderson, S. K.; Lerman, M. I.
  3. Journal of Pathology. 2007, Apr; 211(5): 591-601.
  1. 25.   IL-15 induces C4+ effector memory T cell production and tissue emigration in nonhuman primates
  2. Picker, L. J.; Reed-Inderbitzin, E. F.; Hagen, S. I.; Edgar, J. B.; Hansen, S. G.; Legasse, A.; Planer, S.; Piatak, M.; Lifson, J. D.; Maino, V. C.; Axthelm, M. K.; Villinger, F.
  3. Journal of Clinical Investigation. 2006, JUN; 116(6): 1514-1524.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel